Press Releases on November 5, 2024 - EIN Presswire - Press Release Distribution Service

Published on November 5, 2024 - 14:00 GMT

Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting

FREDERICK, Md., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that safety and tolerability data …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2024 - 14:00 GMT

Affimed Announces Acceptance of Three Abstracts at the 2024 ASH Annual Meeting Including an Oral Presentation Underscoring ...

MANNHEIM, Germany, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced three abstracts …

Distribution channels: Media, Advertising & PR, Technology ...

Published on November 5, 2024 - 14:00 GMT

Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease ...

Initial Results from BEACON Phase 1/2 Clinical Trial Demonstrate Potential for Differentiation of Base Editing and BEAM-101 Preclinical ESCAPE Data Establish Proof-of-concept for Non-genotoxic, Antibody-based Conditioning and Engraftment in Non-human …

Distribution channels: Business & Economy ...

Published on November 5, 2024 - 14:00 GMT

Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the ...

SOMERVILLE, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Tessera Therapeutics, a biotechnology company pioneering a new approach to genome engineering through the development of its Gene Writing™ and delivery platforms, today announced three presentations of …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 5, 2024 - 14:00 GMT

C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at ...

WATERTOWN, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that two abstracts from the ongoing …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2024 - 14:00 GMT

Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting

WALTHAM, Mass. and BOULDER, Colo., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced two presentations featuring …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2024 - 14:00 GMT

Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

Oral presentation of complete data from Phase 1b trial of DISC-0974 in anemia of myelofibrosis (MF) Poster presentations across all programs, including updates from ongoing clinical studies and new translational data in preclinical models supporting use in …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 5, 2024 - 14:00 GMT

Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma

– Data demonstrates Kronos Bio's approach to targeting oncogenic transcription factors and the strong relationship between IRF4 and p300 in Multiple Myeloma – – Poster presentation to take place on Monday, December 9, 2024 – SAN MATEO, Calif. and …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2024 - 14:00 GMT

FortisBC Inc. joins General Fusion's Market Development Advisory Committee to examine potential for fusion energy deployment

RICHMOND, British Columbia, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Today, General Fusion announced that FortisBC Inc. (FortisBC), a regulated utility providing safe and reliable electricity, has joined its Market Development Advisory Committee (MDAC). With …

Distribution channels: Media, Advertising & PR ...

Published on November 5, 2024 - 14:00 GMT

Electromagnetic Survey Identifies Multiple Strong Targets Coincident with Elevated Gold and Silver at Star River

VANCOUVER, British Columbia, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Yukon Metals Corp. (CSE: YMC, FSE: E770, OTC: YMMCF – the “Company” or “Yukon Metals”), is pleased to provide an update from the 2024 reconnaissance fieldwork on its 715-hectare Star River …

Distribution channels: Banking, Finance & Investment Industry, Mining Industry ...

Published on November 5, 2024 - 14:00 GMT

NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024

CARMEL, Ind., Nov. 05, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2024 - 14:00 GMT

PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics ...

– New Appointment of Isaac Ro to Board of Directors Brings Broad Diagnostic Industry & Operations Experience to Company – SAN MATEO, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- PrognomiQ – a healthcare company focused on harnessing the power of multi- …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on November 5, 2024 - 14:00 GMT

Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition

LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2024 - 14:00 GMT

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, will release its financial results for the third …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 5, 2024 - 14:00 GMT

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral ...

LONDON, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announces the online publication of four abstracts submitted to the …

Distribution channels: Culture, Society & Lifestyle ...

Published on November 5, 2024 - 14:00 GMT

SAGA Metals Corp. Completes Second & Final Tranche of IPO Prospectus Offering

VANCOUVER, British Columbia, Nov. 05, 2024 (GLOBE NEWSWIRE) -- SAGA Metals Corp. (TSXV: “SAGA”) (FSE: “20H”) (“SAGA” or the “Company”), a North American exploration company focused on critical mineral discovery in Canada, announces that it has completed …

Distribution channels: Banking, Finance & Investment Industry, Mining Industry ...

Published on November 5, 2024 - 14:00 GMT

Nomad The Label US Announces Launch of Luxurious Linen Clothing Collection

San Diego, California, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nomad The Label US, a women’s clothing brand offering timeless designs, effortless elegance, and year-round versatility, is excited to announce the launch of its luxurious linen clothing collection. …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on November 5, 2024 - 14:00 GMT

Blink to establish a £100 million Special Purpose Vehicle to Drive Electric Vehicle Charger Investments, Engaging Axxeltrova ...

Blink Charging is launching a £100 million Special Purpose Vehicle (SPV) aimed at enhancing electric vehicle charging infrastructure. In collaboration with Axxeltrova Capital (“Axxeltrova”), this initiative will enable Blink to deploy significant assets …

Distribution channels: Automotive Industry ...

Published on November 5, 2024 - 14:00 GMT

Free Gold IRA Kit Now Available For Download

Dallas, TX, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Gold Investment Planner, a trusted resource for guidance on self-directed IRAs and precious metals companies, releases a free gold kit and answers investors’ most popular questions about gold investments. As …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on November 5, 2024 - 14:00 GMT

Bybit Powered by SATOS Introduces Exclusive Referral Bonuses for Dutch Users

AMSTERDAM, The Netherlands, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Bybit (powered by SATOS) is pleased to announce it has elevated Bybit’s global referral program with a special Dutch chapter, the exclusive Referral Rush for users in the Netherlands. Offering …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...